Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Intercept Pharmaceuticals, Inc. (ICPT) since 2014 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Intercept Pharmaceuticals, Inc.. (See page 1 of this report.) Table 2 shows the detailed insider transactions. This company's CIK number is 1270073.
Total stock buying since 2014: $56,967,856.
Total stock sales since 2014: $941,992,580.
Total stock option exercises since 2014: $7,441,640.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2021 | 237,000 | $5,036,730 | 2,193 | $53,662 | 0 | $0 |
| 2020 | 0 | $0 | 6,291,496 | $370,845,750 | 0 | $0 |
| 2019 | 6,407 | $414,286 | 116,877 | $12,174,932 | 89,362 | $2,226,137 |
| 2018 | 798,045 | $51,074,880 | 1,569,444 | $164,779,277 | 57,425 | $613,786 |
| 2017 | 0 | $0 | 65,976 | $8,076,305 | 44,835 | $434,950 |
| 2016 | 0 | $0 | 56,747 | $8,693,631 | 61,626 | $600,726 |
| 2015 | 0 | $0 | 866,879 | $239,356,188 | 191,613 | $1,984,898 |
| 2014 | 2,800 | $441,960 | 477,468 | $138,012,835 | 163,199 | $1,581,143 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2015-02-20 | Williams Nicole | Option Ex | 974 | 9.82 | 9,566 |
| 2015-02-17 | Shapiro David (CMO and EVP - Development) | Sale | 4,646 | 209.23 | 972,082 |
| 2015-02-17 | Shapiro David (CMO and EVP - Development) | Option Ex | 8,794 | 9.53 | 83,833 |
| 2015-02-10 | Veitinger Klaus R Dr | Sale | 233 | 195.52 | 45,556 |
| 2015-02-10 | Veitinger Klaus R Dr | Option Ex | 233 | 21.50 | 5,009 |
| 2015-01-30 | Regan Daniel Paul (Chief Commercial Officer) | Sale | 9,847 | 203.60 | 2,004,878 |
| 2015-01-30 | Regan Daniel Paul (Chief Commercial Officer) | Option Ex | 9,847 | 37.69 | 371,133 |
| 2015-01-30 | Shapiro David (CMO and EVP - Development) | Sale | 7,500 | 206.33 | 1,547,490 |
| 2015-01-30 | Shapiro David (CMO and EVP - Development) | Option Ex | 7,500 | 9.53 | 71,497 |
| 2015-01-20 | Williams Nicole | Sale | 973 | 151.32 | 147,234 |
| 2015-01-20 | Williams Nicole | Option Ex | 973 | 9.82 | 9,556 |
| 2015-01-12 | Veitinger Klaus R Dr | Sale | 233 | 150.01 | 34,952 |
| 2015-01-12 | Veitinger Klaus R Dr | Option Ex | 233 | 21.50 | 5,009 |
| 2015-01-05 | Regan Daniel Paul (Chief Commercial Officer) | Sale | 146 | 176.49 | 25,766 |
| 2015-01-05 | Shapiro David (CMO and EVP - Development) | Sale | 664 | 172.63 | 114,626 |
| 2015-01-05 | Pruzanski Mark (CEO & President) | Sale | 461 | 176.49 | 81,360 |
| 2015-01-05 | Duncan Barbara Gayle (Chief Financial Officer) | Sale | 141 | 176.49 | 24,884 |
| 2015-01-02 | Shapiro David (CMO and EVP - Development) | Sale | 376 | 158.71 | 59,674 |
| 2015-01-02 | Duncan Barbara Gayle (Chief Financial Officer) | Sale | 1,000 | 156.40 | 156,400 |
| 2015-01-02 | Duncan Barbara Gayle (Chief Financial Officer) | Option Ex | 1,000 | 31.90 | 31,900 |
| 2015-01-01 | Shapiro David (CMO and EVP - Development) | Option Ex | 1,623 | .00 | 0 |
| 2015-01-01 | Pruzanski Mark (CEO & President) | Option Ex | 4,868 | .00 | 0 |
| 2015-01-01 | Adorini Luciano (Chief Scientific Officer) | Option Ex | 649 | .00 | 0 |
| 2015-01-01 | Duncan Barbara Gayle (Chief Financial Officer) | Option Ex | 1,298 | .00 | 0 |
| 2014-12-15 | Benatti Luca | Buy | 800 | 139.86 | 111,888 |
| 2014-12-10 | Veitinger Klaus R Dr | Sale | 233 | 144.16 | 33,589 |
| 2014-12-10 | Veitinger Klaus R Dr | Option Ex | 233 | 21.50 | 5,009 |
| 2014-11-19 | Pruzanski Mark (CEO & President) | Option Ex | 6,716 | 15.08 | 101,297 |
| 2014-11-17 | Shapiro David (CMO and EVP - Development) | Sale | 4,790 | 158.91 | 761,198 |
| 2014-11-17 | Shapiro David (CMO and EVP - Development) | Option Ex | 4,000 | 10.40 | 41,600 |
| 2014-11-12 | Akkaraju Srinivas | Buy | 2,000 | 165.04 | 330,072 |
| 2014-11-11 | Akkaraju Srinivas | Option Ex | 2,500 | 21.50 | 53,750 |
| 2014-11-10 | Veitinger Klaus R Dr | Sale | 233 | 175.95 | 40,996 |
| 2014-11-10 | Veitinger Klaus R Dr | Option Ex | 233 | 21.50 | 5,009 |
| 2014-11-03 | Pruzanski Mark (CEO & President) | Sale | 10,000 | 255.79 | 2,557,880 |
| 2014-11-03 | Pruzanski Mark (CEO & President) | Option Ex | 10,000 | 8.67 | 86,670 |
| 2014-10-16 | Akkaraju Srinivas | Option Ex | 324 | .00 | 0 |
| 2014-10-10 | Veitinger Klaus R Dr | Sale | 391 | 223.65 | 87,447 |
| 2014-10-10 | Veitinger Klaus R Dr | Option Ex | 391 | 21.50 | 8,406 |
| 2014-10-02 | Shapiro David (CMO and EVP - Development) | Sale | 832 | 233.97 | 194,663 |
| 2014-10-01 | Shapiro David (CMO and EVP - Development) | Sale | 4,188 | 230.64 | 965,924 |
| 2014-10-01 | Shapiro David (CMO and EVP - Development) | Option Ex | 5,622 | 5.20 | 29,234 |
| 2014-10-01 | Pruzanski Mark (CEO & President) | Sale | 10,000 | 230.49 | 2,304,850 |
| 2014-10-01 | Pruzanski Mark (CEO & President) | Option Ex | 14,867 | 4.33 | 64,418 |
| 2014-10-01 | Adorini Luciano (Chief Scientific Officer) | Option Ex | 649 | .00 | 0 |
| 2014-10-01 | Duncan Barbara Gayle (Chief Financial Officer) | Sale | 1,000 | 233.90 | 233,897 |
| 2014-10-01 | Duncan Barbara Gayle (Chief Financial Officer) | Option Ex | 2,299 | 15.95 | 36,669 |
| 2014-09-15 | Shapiro David (CMO and EVP - Development) | Sale | 4,000 | 283.04 | 1,132,168 |
| 2014-09-15 | Shapiro David (CMO and EVP - Development) | Option Ex | 4,000 | 10.40 | 41,600 |
| 2014-09-10 | Veitinger Klaus R Dr | Sale | 391 | 280.50 | 109,675 |
| 2014-09-10 | Veitinger Klaus R Dr | Option Ex | 391 | 21.50 | 8,406 |
| 2014-09-02 | Pruzanski Mark (CEO & President) | Sale | 10,000 | 287.47 | 2,874,700 |
| 2014-09-02 | Pruzanski Mark (CEO & President) | Option Ex | 10,000 | 8.67 | 86,670 |
| 2014-08-27 | Shapiro David (CMO and EVP - Development) | Sale | 10,000 | 294.67 | 2,946,710 |
| 2014-08-27 | Shapiro David (CMO and EVP - Development) | Option Ex | 10,000 | 8.67 | 86,670 |
| 2014-08-26 | Silverstein Jonathan | Sale | 61,258 | 300.74 | 18,422,424 |
| 2014-08-26 | Isaly Samuel D | Sale | 61,258 | 300.74 | 18,422,424 |
| 2014-08-25 | Williams Nicole | Sale | 2,433 | 295.08 | 717,936 |
| 2014-08-25 | Silverstein Jonathan | Sale | 50,000 | 296.01 | 14,800,500 |
| 2014-08-25 | Isaly Samuel D | Sale | 50,000 | 296.01 | 14,800,500 |
| 2014-08-15 | Shapiro David (CMO and EVP - Development) | Sale | 4,774 | 290.08 | 1,384,851 |
| 2014-08-15 | Shapiro David (CMO and EVP - Development) | Option Ex | 4,000 | 10.40 | 41,600 |
| 2014-08-14 | Silverstein Jonathan | Sale | 60,000 | 300.36 | 18,021,780 |
| 2014-08-14 | Isaly Samuel D | Sale | 60,000 | 300.36 | 18,021,780 |
| 2014-08-12 | Regan Daniel Paul (Chief Commercial Officer) | Sale | 8,124 | 325.90 | 2,647,587 |
| 2014-08-12 | Regan Daniel Paul (Chief Commercial Officer) | Option Ex | 8,124 | 37.69 | 306,193 |
| 2014-08-12 | Adorini Luciano (Chief Scientific Officer) | Sale | 11,038 | 325.98 | 3,598,156 |
| 2014-08-12 | Adorini Luciano (Chief Scientific Officer) | Option Ex | 11,038 | 8.67 | 95,666 |
| 2014-08-12 | Veitinger Klaus R Dr | Sale | 316 | 345.62 | 109,215 |
| 2014-08-12 | Veitinger Klaus R Dr | Option Ex | 316 | 21.50 | 6,794 |
| 2014-08-11 | Fundaro Paolo | Sale | 324 | 239.49 | 77,594 |
| 2014-08-11 | Veitinger Klaus R Dr | Sale | 555 | 237.80 | 131,977 |
| 2014-08-11 | Veitinger Klaus R Dr | Option Ex | 391 | 21.50 | 8,406 |
| 2014-08-09 | Fundaro Paolo | Option Ex | 324 | .00 | 0 |
| 2014-08-09 | Veitinger Klaus R Dr | Option Ex | 324 | .00 | 0 |
| 2014-08-09 | Williams Nicole | Option Ex | 368 | .00 | 0 |
| 2014-08-09 | Silverstein Jonathan | Option Ex | 324 | .00 | 0 |
| 2014-08-09 | Isaly Samuel D | Option Ex | 324 | .00 | 0 |
| 2014-08-01 | Pruzanski Mark (CEO & President) | Sale | 10,000 | 226.72 | 2,267,200 |
| 2014-08-01 | Pruzanski Mark (CEO & President) | Option Ex | 10,000 | 8.67 | 86,670 |
| 2014-07-16 | Akkaraju Srinivas | Option Ex | 325 | .00 | 0 |
| 2014-07-10 | Veitinger Klaus R Dr | Sale | 391 | 219.69 | 85,898 |
| 2014-07-10 | Veitinger Klaus R Dr | Option Ex | 391 | 21.50 | 8,406 |
| 2014-07-07 | Tallarigo Lorenzo | Sale | 2,000 | 243.06 | 486,110 |
| 2014-07-07 | Tallarigo Lorenzo | Option Ex | 2,000 | 9.82 | 19,644 |
| 2014-07-03 | Regan Daniel Paul (Chief Commercial Officer) | Sale | 1 | 250.00 | 250 |
| 2014-07-03 | Regan Daniel Paul (Chief Commercial Officer) | Option Ex | 1 | 37.69 | 37 |
| 2014-07-02 | Shapiro David (CMO and EVP - Development) | Sale | 849 | 247.65 | 210,257 |
| 2014-07-01 | Shapiro David (CMO and EVP - Development) | Sale | 4,187 | 244.09 | 1,022,017 |
| 2014-07-01 | Shapiro David (CMO and EVP - Development) | Option Ex | 5,623 | 5.20 | 29,239 |
| 2014-07-01 | Pruzanski Mark (CEO & President) | Sale | 10,000 | 250.61 | 2,506,120 |
| 2014-07-01 | Pruzanski Mark (CEO & President) | Option Ex | 14,868 | 4.33 | 64,423 |
| 2014-07-01 | Adorini Luciano (Chief Scientific Officer) | Option Ex | 649 | .00 | 0 |
| 2014-07-01 | Duncan Barbara Gayle (Chief Financial Officer) | Option Ex | 1,298 | .00 | 0 |
| 2014-06-16 | Shapiro David (CMO and EVP - Development) | Sale | 4,000 | 277.60 | 1,110,396 |
| 2014-06-16 | Shapiro David (CMO and EVP - Development) | Option Ex | 4,000 | 10.40 | 41,600 |
| 2014-06-02 | Pruzanski Mark (CEO & President) | Sale | 10,000 | 230.60 | 2,305,990 |
| 2014-06-02 | Pruzanski Mark (CEO & President) | Option Ex | 10,000 | 8.67 | 86,670 |
| 2014-05-15 | Shapiro David (CMO and EVP - Development) | Sale | 4,743 | 275.53 | 1,306,819 |
| 2014-05-15 | Shapiro David (CMO and EVP - Development) | Option Ex | 4,000 | 10.40 | 41,600 |
| 2014-05-15 | Fundaro Paolo | Option Ex | 6,922 | 9.82 | 67,987 |
| 2014-05-09 | Fundaro Paolo | Sale | 325 | 232.00 | 75,400 |
| 2014-05-09 | Fundaro Paolo | Option Ex | 325 | .00 | 0 |
| 2014-05-09 | Veitinger Klaus R Dr | Sale | 162 | 230.52 | 37,344 |
| 2014-05-09 | Veitinger Klaus R Dr | Option Ex | 325 | .00 | 0 |
| 2014-05-09 | Tallarigo Lorenzo | Sale | 367 | 232.00 | 85,144 |
| 2014-05-09 | Tallarigo Lorenzo | Option Ex | 367 | .00 | 0 |
| 2014-05-09 | Williams Nicole | Option Ex | 367 | .00 | 0 |
| 2014-05-09 | Silverstein Jonathan | Option Ex | 325 | .00 | 0 |
| 2014-05-09 | Isaly Samuel D | Option Ex | 325 | .00 | 0 |
| 2014-05-07 | Adorini Luciano (Chief Scientific Officer) | Sale | 2,000 | 259.44 | 518,876 |
| 2014-05-07 | Adorini Luciano (Chief Scientific Officer) | Option Ex | 2,000 | 10.40 | 20,800 |
| 2014-05-07 | Veitinger Klaus R Dr | Sale | 665 | 254.21 | 169,046 |
| 2014-05-07 | Tallarigo Lorenzo | Sale | 1,640 | 259.48 | 425,547 |
| 2014-05-07 | Isaly Samuel D | Option Ex | 1,330 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises of ICPT listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Intercept Pharmaceuticals, Inc. (symbol ICPT, CIK number 1270073) see the Securities and Exchange Commission (SEC) website.